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Prevalence, antibiotic susceptibility profiles and ESBL 
production in Klebsiella pneumoniae and Klebsiella 
oxytoca among hospitalized patients
Abstract
Background and Purpose: Klebsiella pneumoniae and Klebsiella 
oxytoca are the two most common pathogens causing nosocomial infections 
in humans and are of great concern for developing multidrug resistance. In 
the present study, K. pneumoniae and K. oxytoca from clinical samples 
were evaluated for their antibiotic sensitivity patterns against commonly used 
antibiotics and production of extended-spectrum beta-lactamase (ESBL).
Materials and Methods: The isolates were obtained from tracheal 
swabs, sputum, wound swabs, pus, blood and urine samples of hospitalized 
patients. Klebsiella pneumoniae and Klebsiella oxytoca were identified 
by cultural and biochemical methods. Antibiotic sensitivity test was per-
formed by modified Kirby-Bauer disc diffusion technique. ESBL production 
in Klebsiella spp. was confirmed by double disc synergy test.
Results and Conclusion: Out of 500 clinical isolates, 120 were found 
positive for Klebsiella among which 108 were K. pneumoniae and 12 were 
K. oxytoca based on indole test. Prevalence rate of Klebsiella was found 
more prominent in males aged over 50 years, mostly in urine samples. Over-
all resistance pattern of Klebsiella isolates to Ampicillin, Amoxicillin, Cef-
triaxone, Ciprofloxacin, Co-trimoxazole, Gentamicin, Nalidixic acid, 
Tetracycline was 100%, 90%, 45%, 40%, 45%, 25%, 50%, 35% respec-
tively. Multidrug resistance was found more common in K. pneumoniae 
(56%) than in K. oxytoca (50%). Prevalence rate of ESBL producing 
Klebsiella was found 45% among which K. pneumoniae (50%) were found 
more prominent than K. oxytoca (25%). All the ESBL producing Klebsi-
ella isolates were found to be multidrug resistant, showing 100% resistance 
to Ampicillin, Amoxicillin, Ceftriaxone and Ciprofloxacin.
INTRODUCTION
K lebsiella have been considered as one of the major opportunistic pathogens that cause a range of clinical diseases including noso-
comial pneumonia, urinary tract infections and bacteremia in immu-
nocompromised humans (8). Among the five gram-negative pathogens 
for hospital-acquired infections, Klebsiella is the most commonly en-
countered pathogen (14). The leading Klebsiella species giving rise to 
infections in humans are Klebsiella pneumoniae and Klebsiella oxytoca 
(13). K. pneumoniae accounts for 75% to 86% of all Klebsiella species 
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Antibiotic susceptibility test
Susceptibility of bacterial isolates to different antibac-
terial agents was determined on Mueller-Hinton agar by 
modified Kirby-Bauer disc diffusion technique. The 0.5 
McFarland standard isolates were inoculated with sterile 
cotton swab onto Mueller Hinton agar to make a lawn of 
bacterial growth. The plates were incubated overnight at 
37°C and zone of inhibition were measured according to 
the criteria suggested by NCCLS, 2000 (27). Commer-
cially available antimicrobial discs (Hi-Media Laborato-
ries Pvt. Limited, India) that were used included Ampicil-
lin (25 µg), Amoxicillin-clavulanic acid (30 µg), 
Ciprofloxacin (05 µg), Co-trimoxazole (25 µg), Ceftriax-
one (30 µg), Gentamicin (10 µg), Tetracycline (30 µg) 
and Nalidixic acid (30 µg).
Detection of ESBLs
Isolates that exhibited reduced susceptibility to ceftriax-
one (30 µg) were considered as potential producers of ESBL 
(27). ESBL production in Klebsiella spp. was confirmed by 
double disc synergy test as described by Jarlier, 1988 (17). 
An inoculum of 0.5 Mcfarland standard was inoculated 
with sterile cotton swab onto Mueller Hinton agar to make 
a lawn of bacterial growth. 30 µg disc of Ceftriaxone (30 
µg) was placed on the agar plate at a distance of 20 mm 
centre to centre from a Amoxicillin-clavulanic acid (20/10 
µg) disc prior to incubation. The plate was incubated over-
night at 37°C. Enhancement of the zone of inhibition of 
Ceftrioxone disc toward Amoxicillin-clavulanic acid con-
firmed the presence of extended-spectrum b-lactamases.
Statistical analysis
Analysis was performed by using Statistical Package 
for Social Science (SPSS Version 16) software and Excel 
Office program for the statistical analysis of this study. 
The t-test was done as a test of significance.
RESULTS
Prevalence of Klebsiella (K. 
pneumonae and K. oxytoca)
Out of 500 samples from clinical patients, Klebsiella 
spp. were reported in 120 cases through standard cul-
tural and biochemical tests. Out of these 120 Klebsiella 
spp. 108 were K. pneumoniae and 12 were found K. oxyt-
oca based on indole test. The prevalence rate of Klebsiella 
was about 24% among which K. pneumoniae accounted 
in 21.6% cases and K. oxytoca in 2.4% cases (Fig. 1).
Highest prevalence was observed in case of urine sample 
(66%), followed by swab in 17% cases, pus in 10% cases 
and sputum in 7% cases (Fig. 2). Males were more affected 
(57%) with Klebsiella spp. than females (43%) (Fig. 3).
Persons older than 50 years irrespective of gender were 
more affected with Klebsiella spp., 58% in male and 36% 
Emergence of antimicrobial resistance among Klebsi-
ella species is becoming a global public health concern. 
High rate of antibiotic resistance is an inevitable con-
sequence of widespread use of antibiotics in medical prac-
tice in developing countries (28, 30). In addition, resis-
tance to broad spectrum beta-lactam antibiotics via 
extended-spectrum beta-lactamase (ESBL) production is 
an increasing problem worldwide (24). Klebsiella and E. 
coli were reported to be the most common pathogenic 
microorganisms to develop resistance to broad spectrum 
beta-lactam antibiotics via extended-spectrum beta-lac-
tamase (ESBL) (2). Several risk factors for ESBL-produc-
ing Klebsiella spp. infections have been described for the 
most frequent antimicrobial exposure, especially to third-
generation cephalosporins (18, 25) which resulted in in-
creased morbidity, mortality and costs of health care. 
Failure in the treatment of infectious diseases especially 
caused by Klebsiella, therefore, need to be under con-
trolled monitoring in developing countries like Bangla-
desh to avoid widespread distribution of multidrug resis-
tant Klebsiella spp.
Therefore, the present study aims to evaluate the prev-
alence of K. pneumonia and K. oxytoca among clinical 
patients and to analyze ESBL production and antimicro-
bial susceptibility pattern against most commonly pre-
scribed antibiotics in order to treat patients with diseases 
caused by K. pneumonia and K. oxytoca.
MATERIALS AND METHODS
Sample collection and processing
A total of 500 clinical samples including blood, urine, 
pus and sputum were obtained from Popular Diagnostic 
Centre and Medinova Diagnostic Centre of Sylhet 
branch, Bangladesh from November 2013 to October 
2014. The patients were of different ages and also of both 
sexes. The collected samples were then collected and pro-
cessed according to standard operating conditions.
Isolation and identification of 
Klebsiella
Klebsiella were isolated and identified by culturing the 
clinical samples onto MacConkey agar plate where large 
mucoid colonies were selected. The selected colonies were 
further confirmed by culturing on Eosine Methylene Blue 
(EMB) agar plate. Then the presumptively identified 
Klebsiella colonies were checked for their Gram staining 
reaction.
Biochemical characterization
Biochemical tests employed were IMViC (Indole, 
Methyl red, Voges Proskeaur, Citrate), fermentation of 
sugars, oxidase and catalase test. For biochemical tests 
standard procedures were used (7).
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in case of female (Fig. 3). The occurrence of infection due 
to Klebsiella spp. was found almost equivalent throughout 
the 12 months with some inclination in the months of 
June (12% for male and 19% for female) and July (16% 
for male and 19% for female) (Fig. 4).
Antibitic sensitivity pattern of 
Klebsiella
The resistance pattern of Klebsiella isolates to Ampicil-
lin, Amoxicillin, Ceftriaxone, Ciprofloxacin, Co-trimox-
azole, Gentamicin, Nalidixic acid, Tetracycline was 
100%, 90%, 45%, 40%, 45%, 25%, 50%, 35% respec-
tively (Fig. 5). Highest sensitivity was observed against 
Gentamicin (75%) followed by Tetracycline (65%). Mul-
tidrug resistance (MDR) was observed in 55% of Klebsi-
ella isolates where 12 isolates out of 120 were found resis-
tant against all the antibiotics tested.
Antibiogram of K. pneumoniae revealed resistance to 
Ampicillin, Amoxicillin, Ceftriaxone, Ciprofloxacin, Co-
trimoxazole, Gentamicin, Nalidixic acid, Tetracycline by 
100%, 94%, 50%, 37.5%, 44%, 31%, 44% and 31% re-
spectively (Fig. 6). Antibiotics that were found most po-
tent against K. pneumoniae was Gentamicin and Tetracy-
cline (69% in both cases) followed by Ciprofloxacin 
(62.5%). Multidrug resistance was observed among 56% 
K. pneumoniae isolates.
Our data showed that K. oxytoca was 100% resistant 
towards Ampicillin which was similar to K. pneuminiae. 
However, unlike K. pneumoniae, K. oxytoca revealed re-
sistance to Amoxicillin, Ceftriaxone, Ciprofloxacin, Co-
Fig. 1. Prevalence rate of K. pneumoniae and K. oxytoca among 
clinical samples.
Fig. 2. Occurrences of Klebsiella spp. in different clinical samples.
Fig. 3. Occurrences of Klebsiella spp. among different age groups.
Fig. 4. Monthly occurrence rate of Klebsiella spp.
Fig. 5. Antibiotic resistance pattern of Klebsiella isolates.
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trimoxazole, Gentamicin, Nalidixic acid, Tetracycline by 
75%, 25%, 50%, 50%, 0%, 75% and 50% respectively 
(Fig. 6). Gentamicin was found to be the most potential 
drug followed by Ceftrioxone. Multidrug resistance was 
observed among 50% K. oxytoca isolates.
Potential ESBL among Klebsiella spp.
Primarily 65% of the Klebsiella isolates were identified 
as potential ESBL producer through the critical zone di-
ameter concept, among which 69% were K. pneumoniae 
and 50% were K. oxytoca. However, the double disc syn-
ergy test revealed that 45% Klebsiella isolates possess 
ESBL property among which K. pneumoniae were 50% 
and K. oxytoca were 25%.
DISCUSSION
The high prevalence rate of Klebsiella among clinical 
patients has become a global concerns in recent years. In 
the present study, 24% prevalence rate of Klebsiella was ob-
served among clinical patients from north eastern part of 
Bangladesh which is alarming since less prevalence rate 
(19.72%) was observed previously in south eastern part of 
Bangladesh by Akter et al., 2014 (3). This difference in 
prevalence rate may be acceptable because the prevalence 
of Klebsiella infections varies in different geographical loca-
tions (33). The two clinically relevant species, K. pneumoni-
ae and K. oxytoca was differentiated by the ability to produce 
indole from tryptophan (21). Majority of the isolates in the 
present study proved to be K. pneumoniae (90%) which is 
in good agreement with previous studies (12, 38). For both 
organisms, however, prevalence was higher in males than 
in the female samples. Female in the age group of 31-40 
years and greater than 50 years were found to be very much 
prone to Klebsiella associated infection whereas male has 
highest incidence of infection on age group greater than 50 
years. Similar results have been previously reported by sev-
eral investigators in Bangladesh who reported that men and 
women of elderly group were found to be very much prone 
to Klebsiella infection (3, 20). In Pakistan, males of older 
age and females of reproductive age were more prone to 
Klebsiella infections particularly by ESBL producers (33). 
Most of the Klebsiella were recovered from urine samples 
irrespective of age and gender, followed by swab, sputum 
and pus. Akter et al., 2014 (3) and Riaz et al., 2012 (33) also 
reported that urine is the principal source of Klebsiella.
Our data suggest that rates of Klebsiella incidence reach 
to the peak in the month of June and July, which are the 
two most humid and warmest months in Bangladesh. 
Such findings have been also observed by Anderson et al., 
2008 (4) who demonstrated that environmental pressure 
during the warmest months may lead to an increase in 
Klebsiella infection. Characteristics of Klebsiella might 
have some role on such seasonal variation. Klebsiella are 
the most heat tolerant among all enteric pathogens (29) 
having maximal specific growth rate at 37°C (9). In addi-
tion, they are believed to survive at higher humidity (36).
The effectiveness of currently available antibiotics is 
decreasing due to the increasing number of resistant 
strains causing infections (26). Available therapeutic op-
tions for antibiotic-resistant organisms are severely limit-
ed, as these organisms frequently display a multidrug-re-
sistant (MDR) phenotype (19, 23, 31). In the present 
study, K. pneumoniae and K. oxytoca demonstrated vary-
ing degree of sensitivity pattern to different antibiotics. 
Most of the Klebsiella isolates showed resistance to the first 
line antibiotics that are commonly prescribed by the phy-
sicians. Our data showed that all the K. pneumoniae iso-
lates were resistant to Ampicillin. Moderate level sensitiv-
ity were observed against Ceftriaxone, Ciprofloxacin, 
Co-trimoxazole, Gentamicin, Nalidixic acid and Tetracy-
cline among which Gentamicin and Tetracycline showed 
good promise. Gentamicin like aminoglycosides have a 
good record against clinically important Gram-negative 
bacilli (10). Recently in India and Pakistan, about 16.70% 
and 17.39% Klebsiella isolates were found sensitive against 
Gentamicin (32, 37). The difference among our data and 
the previously found lower sensitivity against Gentamicin 
may be due to selective pressure in different regions (22).
Emergence of multidrug resistant Klebsiella has be-
come a major public health concern worldwide and has 
been associated with outbreaks of hospitalized infections 
in developing countries like Bangladesh due to the indis-
criminate use of antibiotics (3). In the present study, mul-
tidrug resistance was found more common in K. pneu-
moniae (56%) than in K. oxytoca (50%). Various degrees 
of multidrug resistance among Klebsiella have been re-
ported in different parts of the world. In Bangladesh, 
about 87% multidrug resistant Klebsiella were recorded 
(20) whereas in India and Pakistan, 54% and 71.73% 
Klebsiella isolates were reported to harbor multidrug resis-
tance (35, 37). Chikwendu et al., 2010 in Nigeria report-
ed 75.8% multidrug resistant Klebsiella isolates (6). Most 
recently, Gundogan and Avci, 2013, reported that 31.7% 
Klebsiella isolates possess multidrug resistance (11).
Fig. 6. Comparative antibiotic resistance pattern of K. pneumoniae 
and K. oxytoca.
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ESBL producing Klebsiella pose great challenges for ef-
ficient treatment of infections which requires new antibac-
terial compounds every now and then. Our study focused 
on the present status of ESBL producing Klebsiella. Inter-
estingly all the ESBL producing Klebsiella isolates were 
found to be multidrug resistant, showing 100% resistance 
to Ampicillin, Amoxicillin, Ceftriaxone and Ciprofloxacin 
indicating relationship between multidrug resistance and 
ESBL possession. However, 12.5% non-ESBL K. pneu-
moniae possess multidrug resistance property while 33% 
of the non-ESBL K. oxytoca harbour multidrug resistance.
The prevalence rate of ESBL producing Klebsiella is 
very high (45%) in our study as compared to previous 
studies such as 40% in France (5) and 17% in Pakistan 
(33). However, the present result for the occurrences of 
ESBL among Klebsiella isolates is significantly better than 
previous studies by Sharma et al., 2013 (34) and Jain and 
Mondal, 2007 (15) who found much higher rate (67.04% 
and 58%, respectively). ESBL producing K. pneumoniae 
(50%) were found more prominent than K. oxytoca (25%). 
In case of ESBL producing K. oxytoca, our result is in good 
agreement with the studies by Gundogan and Avci, 2013, 
who found that 26% K. oxytoca were ESBL producer (11). 
However, in case of ESBL producing K. pneumoniae, the 
rate is much higher than found by Gundogan and Avci, 
2013 (38.5%) (11). Such high rate of ESBL among K. 
pneumoniae might be due to inappropriate use of antibiot-
ics and self-medication against K. pneumoniae infection. 
However, our results are significantly better for ESBL 
producing K. pneumoniae than found by Afifi (2013) in 
Egypt (56.25%), Jain et al. (2003) in India (86.6%) and 
Ullah et al. (2009) in Pakistan (58.5%) (1, 16, 37).
The high frequencies with which antibiotics are used 
empirically to treat various diseases in Bangladesh suggest 
that there might be high rate of failure associated with 
eradication of microbial infections. Our results suggest 
that there is high antibiotic resistance towards common-
ly prescribed antibiotics and ESBLs rates among clinical 
Klebsiella isolates in the specific region of the country. 
Further studies need to be carried out from other parts of 
Bangladesh considering multidrug resistance and ESBL 
production rate among clinical and non clinical Klebsi-
ella isolates. Continuous monitoring of ESBL, strict anti-
biotic policy along with conventional antibiogram will 
have a great impact in reducing bacterial resistance to-
wards antibiotics and development of proper treatment 
options against Klebsiella infections.
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